John Stevenson speaks with Matthew Moulding, Founder and CEO of THG about how THG Nutrition is scaling, and what’s next:
• Offline explosion: Licensing & B2B revenues have grown from a standing start to ~£200m in under three years; we unpack the future opportunity, margin progression and brand exposure.
• Whey on margins: A normalised whey price could drive £50m+ margin recovery. We also cover differentiated core products, the Ozempic effect and NPD.
• Just getting started: As a $1bn revenue brand scaling across categories and channels—would you sell it? What is the long‑term value?
THG Nutrition has returned to double‑digit DTC growth while offline revenue scales rapidly in the UK and overseas - a timely conversation on the outlook from here.
Watch the conversation below.
